Scion Drugs Private Limited - Company Profile

It is a pharma private limited company based in Meerut, Uttar Pradesh, India, established in 2016.
2016 Meerut, Uttar Pradesh, India Active
Last Updated:
Access Report
About Scion Drugs Private Limited

Scion Drugs Private Limited, a active private limited company, was established on 16 August 2016 in Meerut, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24305UP2016PTC085643. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.

It upholds a active non-compliant status. Its leadership includes Rahul Chaudhry (Director), Umesh Kumar (Director). It is based at H.No B-87, Europian Estate, Kanker Khera,, Meerut, Uttar Pradesh, 250001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24305UP2016PTC085643

  • Registration Number

    085643

  • Incorporation Date

    16 August 2016

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 9 Year, 6 Months
Company report

Scion Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Scion Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Scion Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Rahul Chaudhry Director 16 Aug 2016 Current
Umesh Kumar Director 16 Aug 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Scion Drugs.

Enhance accessibility to Scion Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Scion Drugs revenue growth over time
Scion Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Scion Drugs?

Unlock access to Scion Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Scion Drugs?

Unlock and access historical data on people associated with Scion Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Scion Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scion Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Scion Drugs
Recent Activity within the Organization
  • Director Appointment

    Rahul Chaudhry was appointed as a Director was appointed as a Director on 16 Aug 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.

  • Director Appointment

    Umesh Kumar was appointed as a Director was appointed as a Director on 16 Aug 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Scion Drugs Private Limited was registered on 16 Aug 2016 with Roc Kanpur & aged 9 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Scion Drugs Private Limited?

The CIN of Scion Drugs Private Limited is U24305UP2016PTC085643.

Where is Scion Drugs Private Limited headquartered?

Scion Drugs Private Limited is headquartered at H.No B-87, Europian Estate, Kanker Khera,, Meerut, Uttar Pradesh, 250001.

When was Scion Drugs Private Limited incorporated?

Scion Drugs Private Limited was incorporated on 16 August 2016.

Who are the current directors of Scion Drugs Private Limited?

The current directors of Scion Drugs Private Limited are

What is the primary industry of Scion Drugs Private Limited?

The primary industry of Scion Drugs Private Limited is Pharma.

Is Scion Drugs Private Limited a listed company?

Scion Drugs Private Limited is unlisted.

What is the capital structure of Scion Drugs Private Limited?

The authorized capital of Scion Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.

What is the compliance status of Scion Drugs Private Limited?

The compliance status of Scion Drugs Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available